NewAmsterdam Pharma Co N.V. SEC filings NAMSW
NewAmsterdam Pharma Co N.V. has 415 filings in SEC EDGAR's recent list, going back to Aug 4, 2022. Its latest annual report, Form ARS, was filed on May 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 10, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2025 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2024 | — |
| EFFECT | Filing | Aug 12, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2024 | — |
| EFFECT | Filing | Jul 12, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2024 | — |
| EFFECT | Filing | Apr 17, 2024 | — |
| EFFECT | Filing | Mar 8, 2024 | — |
| EFFECT | Filing | Dec 19, 2023 | — |
| CORRESP | Letter to the SEC | Dec 15, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| EFFECT | Filing | Apr 24, 2023 | — |
| EFFECT | Filing | Jan 30, 2023 | — |
| CORRESP | Letter to the SEC | Jan 26, 2023 | — |
| CORRESP | Letter to the SEC | Jan 17, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2023 | — |
| CERT | Filing | Nov 22, 2022 | — |
| 8-A12B | Filing | Nov 22, 2022 | — |
| 8-A12B | Filing | Nov 18, 2022 | — |
| 425 | Filing | Nov 16, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 19, 2022 | — |
| EFFECT | Filing | Oct 18, 2022 | — |
| 425 | Filing | Oct 17, 2022 | — |
| CORRESP | Letter to the SEC | Oct 14, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| 425 | Filing | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2022 | — |
| 425 | Filing | Oct 11, 2022 | — |
| 425 | Filing | Oct 5, 2022 | — |
| 425 | Filing | Oct 5, 2022 | — |
| 425 | Filing | Oct 4, 2022 | — |
| CORRESP | Letter to the SEC | Oct 3, 2022 | — |
| 425 | Filing | Sep 29, 2022 | — |
| 425 | Filing | Sep 28, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2022 | — |
| 425 | Filing | Sep 23, 2022 | — |
| 425 | Filing | Sep 22, 2022 | — |
| 425 | Filing | Sep 21, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| CORRESP | Letter to the SEC | Sep 13, 2022 | — |
| SEC STAFF LETTER | Filing | Aug 31, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| 425 | Filing | Aug 29, 2022 | — |
| 425 | Filing | Aug 24, 2022 | — |
| 425 | Filing | Aug 24, 2022 | — |
| 425 | Filing | Aug 23, 2022 | — |
| 425 | Filing | Aug 19, 2022 | — |
| 425 | Filing | Aug 17, 2022 | — |
| 425 | Filing | Aug 16, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
| 425 | Filing | Aug 9, 2022 | — |
| 425 | Filing | Aug 8, 2022 | — |
| 425 | Filing | Aug 4, 2022 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NAMS (Nasdaq), NAMSW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Narrden, Netherlands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1936258
- Former names
- NewAmsterdam Pharma Co B.V. (until Nov 22, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.